High-Sensitivity CRP Mediates Age-Related Vascular Dysfunction: Rotterdam Study Insights
Overview
This study from the Rotterdam cohort demonstrates that systemic inflammation, measured by high-sensitivity C-reactive protein (hsCRP), significantly mediates the relationship between aging and vascular dysfunction. The mediation effect of hsCRP on arterial stiffness and thickness is comparable to lipid markers and is more pronounced in men. Mendelian randomization supports a potential causal role of hsCRP in vascular stiffness but not in arterial wall thickening.
Background
Cardiovascular disease risk increases with age due to vascular changes such as arterial stiffening and intima-media thickening. While lipid metabolism has been traditionally implicated in vascular damage, chronic low-grade inflammation (inflammaging) marked by elevated hsCRP is increasingly recognized as a contributor. The biological mechanisms linking inflammation and vascular aging remain incompletely understood, with potential sex differences in inflammatory pathways. This study investigates the mediating role of hsCRP in age-related vascular dysfunction and compares it with lipid markers, using data from a large population-based cohort.
Data Highlights
Parameter
Mediation Effect (%)
P-value
Sex Difference
hsCRP on cIMT
2.66%
0.001
Stronger in men
hsCRP on PWV
2.56%
4.95 × 10⁻⁹
Stronger in men
Lipid markers (total cholesterol, HDL)
Comparable mediation magnitude
Not specified
Not specified
Key Findings
hsCRP significantly mediates the effect of age on carotid intima-media thickness (cIMT) and pulse wave velocity (PWV), markers of vascular remodeling and stiffness respectively.
The mediation effect of hsCRP is approximately 2.5-2.7%, comparable to that of lipid markers such as total cholesterol and HDL.
Mediation by hsCRP is stronger in men than in women, suggesting sex-specific inflammatory pathways in vascular aging.
Mendelian randomization analysis supports a potential causal relationship between genetically elevated hsCRP and increased PWV but not with cIMT.
Findings suggest that systemic inflammation contributes to functional vascular aging, particularly arterial stiffness, beyond lipid-related mechanisms.
Clinical Implications
These results highlight the importance of systemic inflammation, as indexed by hsCRP, in the pathophysiology of age-related vascular dysfunction, especially arterial stiffness. Clinicians should consider that anti-inflammatory strategies may complement lipid-lowering therapies to reduce cardiovascular risk in aging populations. Additionally, sex-specific differences in inflammatory mediation suggest personalized approaches may be warranted.
Conclusion
Systemic inflammation measured by hsCRP partially mediates and may causally contribute to vascular stiffness with aging, particularly in men. Targeting inflammation alongside lipid metabolism could enhance prevention of cardiovascular disease associated with vascular aging.
References
Rotterdam Study Group 2024 -- The Role of High-Sensitivity C-Reactive Protein in Age-Related Vascular Dysfunction
